Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Frailty in Patients With Fibrosing Interstitial Lung Diseases: Prognostic and Therapeutic Impact

NCT07004595 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT07004595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07004595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Frailty in Patients With Fibrosing Interstitial Lung Diseases: Prognostic and Therapeutic Impact
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Recruiting
Start date
July 20, 2025
Completion date
December 20, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sarcopenia